Vasculitis Foundation of Canada logo

GPA & MPA Genetics Study Moves to Phase 2 for Rare and Lethal Vasculitis Diseases

The different Phases of Genetic Research 1. Study the underlying genetics + 2. Study the protein interplay = 3. Vastly Better Treatment Vasculitis Foundation Canada (VFC), is pleased to announce a bold new direction in a longstanding genetics study on two rare, but lethal, vasculitis

New Trial – Assessment of Prednisone in Remission

If you wish to participate, please consult the Rare Diseases Clinical Research Network website at the following link

Courtesy Posting – Erna Baird Memorial Grant

Today commemorates the third anniversary of Erna Baird’s passing on June 6, 2011, due to complications from Granulomatosis with Polyagiitis (formerly Wegener’s Granulomatosis), and the establishment of The Erna Baird Memorial Grant (EBMG). In loving memory of a devoted, loving,

Volunteers Needed – Vasculitis Patient Research Network

You want to help? Are you looking for an opportunity to be part of a research? Check out: Vasculitis Patient-Powered Research Network They are accepting applications from June 4 to 13, 2014.

The Assessment of Prednisone In Remission Trial (TAPIR) – Center of Excellence Approach

For Granulomatosis with Polyangiitis (Wegener’s) Patients. For more information please consult the Vasculitis Clinical Research Consortium

VCRC Genetic Repository DNA Study

About this study This update provides information such as a study summary, eligibility criteria, and a list of participating center locations. If you are interested in participating in this study or you have more questions, please contact the center nearest to you. Summary: A total of